Phase I Clinical Trial to Evaluate the Safety and Tolerability of Ophtalmic Solution PRO-201

NCT05470881 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Myopia

Interventions

DRUG: Atropine Sulfate

Sponsor

Laboratorios Sophia S.A de C.V.